GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kwality Pharmaceuticals Ltd (BOM:539997) » Definitions » Return-on-Tangible-Asset

Kwality Pharmaceuticals (BOM:539997) Return-on-Tangible-Asset : 8.67% (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Kwality Pharmaceuticals Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Kwality Pharmaceuticals's annualized Net Income for the quarter that ended in Dec. 2024 was ₹341 Mil. Kwality Pharmaceuticals's average total tangible assets for the quarter that ended in Dec. 2024 was ₹3,935 Mil. Therefore, Kwality Pharmaceuticals's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 was 8.67%.

The historical rank and industry rank for Kwality Pharmaceuticals's Return-on-Tangible-Asset or its related term are showing as below:

BOM:539997' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 2.53   Med: 5.97   Max: 47.35
Current: 7.83

During the past 11 years, Kwality Pharmaceuticals's highest Return-on-Tangible-Asset was 47.35%. The lowest was 2.53%. And the median was 5.97%.

BOM:539997's Return-on-Tangible-Asset is ranked better than
73.22% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.65 vs BOM:539997: 7.83

Kwality Pharmaceuticals Return-on-Tangible-Asset Historical Data

The historical data trend for Kwality Pharmaceuticals's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kwality Pharmaceuticals Return-on-Tangible-Asset Chart

Kwality Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.99 10.13 47.35 5.58 6.36

Kwality Pharmaceuticals Quarterly Data
Mar19 Sep19 Mar20 Sep20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.67 4.51 8.48 8.61 8.67

Competitive Comparison of Kwality Pharmaceuticals's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Kwality Pharmaceuticals's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kwality Pharmaceuticals's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kwality Pharmaceuticals's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Kwality Pharmaceuticals's Return-on-Tangible-Asset falls into.


;
;

Kwality Pharmaceuticals Return-on-Tangible-Asset Calculation

Kwality Pharmaceuticals's annualized Return-on-Tangible-Asset for the fiscal year that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=237.962/( (3536.317+3942.097)/ 2 )
=237.962/3739.207
=6.36 %

Kwality Pharmaceuticals's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=341.188/( (3934.96+0)/ 1 )
=341.188/3934.96
=8.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2024) net income data.


Kwality Pharmaceuticals  (BOM:539997) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Kwality Pharmaceuticals Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Kwality Pharmaceuticals's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Kwality Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Majitha Road, Village Nagkalan, 6th Mile Stone, Amritsar, PB, IND, 143601
Kwality Pharmaceuticals Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing finished pharmaceutical formulations in a dosage form. The company manufactures and exports pharmaceutical formulations in liquid orals, dry syrups, tablets, capsules, sterile powder for injections, and small-volume injectables.

Kwality Pharmaceuticals Headlines

No Headlines